Biotrial, A Leading Provider of Drug Development Services, Has Completed Its Acquisition of Warnex Bioanalytical Services Division – and Is Proud to Introduce the Creation of Bbs: Biotrial Bioanalytical Services
Rennes, France — The acquisition of the Warnex Bioanalytical Services division allows Biotrial to broaden its drug development services to its international clients, giving them access to the...
ICON Reports Fourth Quarter 2012 Revenue of $300 Million, up 24% year on year, EPS of 34c and Full Year revenue of $1.12 billion, EPS of $1.00.
Highlights – Fourth Quarter and Full year ended December 31 2012. Quarter 4 net revenue increased 24% year on year to $300 million. Full Year 2012 net revenue increased 18% to $1.12 billion. ...
THE HAMNER INSTITUTES FOR HEALTH SCIENCES ANNOUNCES PARTNERSHIP WITH QPS HOLDINGS, LLC
Global CRO Establishes New Research Triangle Park, North Carolina Based Operation and Research Center RESEARCH TRIANGLE PARK, N.C. – The Hamner Institutes for Health Sciences, a nonprofit...
AMRI Announces Fourth Quarter 2012 Adjusted EPS of $0.17
Albany, NY – AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2012. Fourth Quarter: Adjusted earnings per share of...
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2012 Results from Continuing Operations
– Fourth-Quarter Sales of $280.1 Million and Full-Year 2012 Sales of $1.13 Billion – – Fourth-Quarter GAAP Earnings per Share of $0.47 and Non-GAAP Earnings per Share of $0.64...
Quintiles Files Registration Statement for Initial Public Offering
RESEARCH TRIANGLE PARK, NC – February 15, 2013 – Quintiles Transnational Holdings, Inc. announced today that it has filed a registration statement with the U.S. Securities and Exchange...
Contract Research Organization, WCCT Global, Announces Specialized Japanese Recruitment Methods for Global Ethnobridging Clinical Studies
WCCT Global, a contract research organization (CRO) supporting Phase I - IV bio-pharmaceutical and device development, today announced the success of their specialized recruitment methods for...
PPD Adds New Central Laboratory Services to Meet Growing Client Needs
WILMINGTON, N.C.--Pharmaceutical Product Development, LLC (PPD) today announced it has strengthened its central laboratory testing services in infectious diseases, one of the largest therapeutic...
GSK announces support for AllTrials campaign for clinical data transparency
GSK today further demonstrated its commitment to clinical trial transparency by announcing its support for the AllTrials campaign. The campaign is calling for registration of clinical trials and the...
Cardiome Selects Quintiles To Manage Global Regulatory Affairs And Life Cycle Safety Activities For BRINAVESS™ (Vernakalant Intravenous)
VANCOUVER, Feb. 4, 2013 -- NASDAQ: CRME TSX: COM Cardiome Pharma Corp. today announced the selection of Quintiles to provide comprehensive post-marketing lifecycle safety and global regulatory...
Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced plans for additional investment in its Milton...
US FDA Extends License of the GVK BIO Biomarker Database
HYDERABAD, India--GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug...
Biopharmaceutical Industry Facing Hiring Difficulties and R&D Talent Gap, Finds PwC Health Research Institute Report
NEW YORK, Feb. 4, 2013 -- A talent gap in the scientific workforce has biopharmaceutical companies searching outside for fresh skills and alternate approaches to R&D staffing, according to...
Solvias acquires CONFARMA
KAISERAUGST/Switzerland - The pharmaceutical service provider Solvias AG announced today the acquisition of CONFARMA AG, headquartered in Münchenstein, and its subsidiary CONFARMA France SARL....
ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare Inc.
Dublin, Ireland, 4th February, 2013 – ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device...
JLL Partners to Acquire BioClinica and CoreLab Partners
NEWTOWN, Pa.--BioClinica®, Inc. (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, today announced that it has entered into a definitive agreement to be acquired by...
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
Service revenue of $422.1 million, up 26.7% year-over-year - GAAP operating margin of 7.4% improves from 6.8% in the second quarter of FY 2012 - Adjusted operating margin of 7.6% improves from...
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results - Service revenue of $422.1 million, up 26.7% year-over-year - GAAP operating margin of 7.4% improves from 6.8% in the second...
Verum.de Chosen to Provide Clinical Research Services for Oncology Center in Romania
SAN DIEGO, Jan. 23, 2013 -- Verum.de, a full-clinical service, German-based contract research organization (CRO) with a new office in Carlsbad, Calif., has entered into an agreement with the Center...
MicroConstants China Signs Site Management Organization Agreement with the Clinical Research Center of No. 307 Hospital
BEIJING, Jan. 28, 2013 -- MicroConstants China Inc., a Contract Research Organization (CRO) conducting preclinical pharmacokinetic studies, early-stage clinical trials, and regulated bioanalysis in...
